GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Expensive Performer
2675.3000 -53.10 (-1.95%)
NSE Apr 09, 2025 15:31 PM
Volume: 73,069
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
05 Aug 2024
2675.30
-1.95%
buy
by ICICI Securities Limited
Target: 2640 | Target met
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
 
GlaxoSmithKline Pharmaceuticals Ltd. is trading below its 30 day SMA of 2726.0
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market closes lower, Mphasis gets US patent for quantum ML prediction system
Trendlyne Marketwatch | 09 Apr 2025, 04:03PM
Chart of the week: Gear shift in two-wheeler market: Hero loses ground to Honda & TVS
The Baseline | 09 Apr 2025, 09:38AM
IPOs This Week: Infonative Solutions and Spinaroo’s Listings, No Upcoming Issues
| 07 Apr 2025